Literature DB >> 27458502

Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.

Vishnubhotla Venkata Ravi Kanth1, Mitnala Sasikala1, Mithun Sharma1, Padaki Nagaraja Rao1, Duvvuru Nageshwar Reddy1.   

Abstract

Genetics plays an important role in determining the susceptibility of an individual to develop a disease. Complex, multi factorial diseases of modern day (diabetes, cardiovascular disease, hypertension and obesity) are a result of disparity between the type of food consumed and genes, suggesting that food which does not match the host genes is probably one of the major reasons for developing life style diseases. Non-alcoholic fatty liver is becoming a global epidemic leading to substantial morbidity. While various genotyping approaches such as whole exome sequencing using next generation sequencers and genome wide association studies have identified susceptibility loci for non-alcoholic fatty liver disease (NAFLD) including variants in patatin-like phospholipase domain containing 3 and transmembrane 6 superfamily member 2 genes apart from others; nutrient based studies emphasized on a combination of vitamin D, E and omega-3 fatty acids to manage fatty liver disease. However majority of the studies were conducted independent of each other and very few studies explored the interactions between the genetic susceptibility and nutrient interactions. Identifying such interactions will aid in optimizing the nutrition tailor made to an individual's genetic makeup, thereby aiding in delaying the onset of the disease and its progression. The present topic focuses on studies that identified the genetic susceptibility for NAFLD, nutritional recommendations, and their interactions for better management of NAFLD.

Entities:  

Keywords:  Genetic susceptibility; Genotyping; Non-alcoholic fatty liver disease; Nutrient interactions; Patatin-like phospholipase domain containing 3 gene; Transmembrane 6 superfamily member 2 gene

Year:  2016        PMID: 27458502      PMCID: PMC4945502          DOI: 10.4254/wjh.v8.i20.827

Source DB:  PubMed          Journal:  World J Hepatol


  65 in total

Review 1.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

2.  A strategy for analyzing gene-nutrient interactions in type 2 diabetes.

Authors:  Carolyn Wise; Jim Kaput
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 3.  Nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Paola Dongiovanni; Claudia Lanti; Patrizia Riso; Luca Valenti
Journal:  J Nutr Biochem       Date:  2015-10-23       Impact factor: 6.048

Review 4.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

5.  Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Authors:  Takuya Kitamoto; Aya Kitamoto; Masato Yoneda; Hideyuki Hyogo; Hidenori Ochi; Takahiro Nakamura; Hajime Teranishi; Seiho Mizusawa; Takato Ueno; Kazuaki Chayama; Atsushi Nakajima; Kazuwa Nakao; Akihiro Sekine; Kikuko Hotta
Journal:  Hum Genet       Date:  2013-03-28       Impact factor: 4.132

6.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

7.  Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.

Authors:  Vishnubhotla Venkata Ravi Kanth; Mitnala Sasikala; Padaki Nagaraja Rao; Urmila Steffie Avanthi; Kalashikam Rajender Rao; Duvvuru Nageshwar Reddy
Journal:  World J Hepatol       Date:  2014-06-27

Review 8.  Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

Authors:  Chin Hee Kim; Zobair M Younossi
Journal:  Cleve Clin J Med       Date:  2008-10       Impact factor: 2.321

9.  Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia.

Authors:  T M Narcisi; C C Shoulders; S A Chester; J Read; D J Brett; G B Harrison; T T Grantham; M F Fox; S Povey; T W de Bruin
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

10.  Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Authors:  Takahisa Kawaguchi; Yoshio Sumida; Atsushi Umemura; Keitaro Matsuo; Meiko Takahashi; Toshinari Takamura; Kohichiroh Yasui; Toshiji Saibara; Etsuko Hashimoto; Miwa Kawanaka; Sumio Watanabe; Sumio Kawata; Yasuharu Imai; Miki Kokubo; Toshihide Shima; Hyohun Park; Hideo Tanaka; Kazuo Tajima; Ryo Yamada; Fumihiko Matsuda; Takeshi Okanoue
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

View more
  7 in total

1.  Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans?

Authors:  Nataša Milošević; Maja Milanović; Jan Sudji; Dragana Bosić Živanović; Stefan Stojanoski; Bojan Vuković; Nataša Milić; Milica Medić Stojanoska
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-06       Impact factor: 4.223

Review 2.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 3.  Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Manuel Suárez; Noemí Boqué; Josep M Del Bas; Jordi Mayneris-Perxachs; Lluís Arola; Antoni Caimari
Journal:  Nutrients       Date:  2017-09-22       Impact factor: 5.717

Review 4.  Non-alcoholic fatty liver disease: An expanded review.

Authors:  Mark Benedict; Xuchen Zhang
Journal:  World J Hepatol       Date:  2017-06-08

5.  An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank.

Authors:  Glen James; Sulev Reisberg; Kaido Lepik; Nicholas Galwey; Paul Avillach; Liis Kolberg; Reedik Mägi; Tõnu Esko; Myriam Alexander; Dawn Waterworth; A Katrina Loomis; Jaak Vilo
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

6.  Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010.

Authors:  Sofia G Verstraete; Janet M Wojcicki; Emily R Perito; Philip Rosenthal
Journal:  Environ Health       Date:  2018-02-01       Impact factor: 5.984

7.  Regional differences in genetic susceptibility to non-alcoholic liver disease in two distinct Indian ethnicities.

Authors:  Govardhan Bale; Avanthi Urmila Steffie; Vishnubhotla Venkata Ravi Kanth; Padaki Nagaraja Rao; Mithun Sharma; Mitnala Sasikala; Duvvur Nageshwar Reddy
Journal:  World J Hepatol       Date:  2017-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.